The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study
- PMID: 11085842
- DOI: 10.7326/0003-4819-133-10-200011210-00012
The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study
Abstract
Background: The clinical significance of the high prevalence of osteopenia in inflammatory bowel disease is unclear.
Objective: To determine whether persons with inflammatory bowel disease have increased incidence of fracture.
Design: Population-based matched cohort study.
Setting: Manitoba, Canada.
Patients: Patients with inflammatory bowel disease in the University of Manitoba IBD Database (n = 6027) were matched to 10 randomly selected persons in the general population without inflammatory bowel disease (n = 60 270) by year, age, sex, and postal area of residence.
Measurements: The incidence of hospitalization for hip fracture was determined on the basis of hospital discharge abstracts. Outpatient medical billing records and hospital discharge abstracts were used to calculate the incidence of spine, rib, and forearm fractures. Rates were calculated on the basis of person-years of follow-up for 1984 to 1997.
Results: Persons with inflammatory bowel disease had significantly increased incidence of fractures at the spine (incidence rate ratio [IRR], 1.74 [95% CI, 1.34 to 2.24]; P < 0.001), hip (IRR, 1.59 [CI, 1.27 to 2.00]; P < 0.001), wrist/forearm (IRR, 1.33 [CI, 1.11 to 1.58]; P = 0.001), and rib (IRR, 1.25 [CI, 1.02 to 1.52]; P = 0.03) and of any of these fractures (IRR, 1.41 [CI, 1.27 to 1.56]; P < 0.001).
Conclusion: The incidence of fracture among persons with inflammatory bowel disease is 40% greater than that in the general population.
Comment in
-
Secondary osteoporosis: the potential relevance of leptin and low body weight.Ann Intern Med. 2000 Nov 21;133(10):828-30. doi: 10.7326/0003-4819-133-10-200011210-00016. Ann Intern Med. 2000. PMID: 11085846 No abstract available.
Similar articles
-
Cancer risk in patients with inflammatory bowel disease: a population-based study.Cancer. 2001 Feb 15;91(4):854-62. doi: 10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z. Cancer. 2001. PMID: 11241255
-
Rib fractures predict incident limb fractures: results from the European prospective osteoporosis study.Osteoporos Int. 2006 Jan;17(1):41-5. doi: 10.1007/s00198-005-1887-3. Epub 2005 Jun 1. Osteoporos Int. 2006. PMID: 15928803
-
High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol. 2022 May;20(5):e1022-e1039. doi: 10.1016/j.cgh.2021.06.026. Epub 2021 Jun 30. Clin Gastroenterol Hepatol. 2022. PMID: 34216823
-
Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.Minerva Med. 2004 Dec;95(6):469-80. Minerva Med. 2004. PMID: 15785432 Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
Diet Recommendations for Hospitalized Patients With Inflammatory Bowel Disease: Better Options Than Nil Per Os.Crohns Colitis 360. 2020 Oct;2(4):otaa059. doi: 10.1093/crocol/otaa059. Epub 2020 Jul 17. Crohns Colitis 360. 2020. PMID: 33954288 Free PMC article.
-
Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease.PLoS One. 2021 Apr 27;16(4):e0250658. doi: 10.1371/journal.pone.0250658. eCollection 2021. PLoS One. 2021. PMID: 33905438 Free PMC article.
-
DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone.Sci Rep. 2019 Oct 22;9(1):15144. doi: 10.1038/s41598-019-51550-w. Sci Rep. 2019. PMID: 31641205 Free PMC article.
-
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.Intest Res. 2022 Oct;20(4):392-417. doi: 10.5217/ir.2021.00160. Epub 2022 May 31. Intest Res. 2022. PMID: 35645322 Free PMC article. Review.
-
Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.Osteoporos Int. 2017 May;28(5):1507-1529. doi: 10.1007/s00198-016-3894-y. Epub 2017 Feb 7. Osteoporos Int. 2017. PMID: 28175979 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical